Given a desert signature of type I IFN in the microenvironment of melanoma, we brought IFNα to the tumor site by employing MSCs constitutively expressing IFNα (IFNα-MSCs) to treat mice with tumors. The gene discussed is IFNA1; the disease is neoplasm.